C2Q-30194-46560

4 vaccinations 5 coded responses 15 check-ins 5 free-text entries 3 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 594 / MT
Registered: 2021-01-20

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Dose 1 — Moderna
2021-01-19
Dose 2 — Moderna
2021-01-20
Registered in v-safe
2021-01-20
Survey response — days 1–6 daily, dose 2
MedDRA: Impaired work ability, Migraine — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Severe migraine, had to call of work (never do that)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea, Diarrhea

Adult check-in
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-01-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-26
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-02
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-09
Survey response — day 21, dose 2
MedDRA: Migraine, Pain — Feeling: Poor · Be unable to do your normal daily activities

Free text: Migraine, aches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-16
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-02
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-20
Survey response — 3 months, dose 2
MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Severe migraine

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-20
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-20
Survey response — 6 months, dose 2
MedDRA: Migraine, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Worsening migraines · Healthcare visit (other): Botox injections

MedDRA releases: 2024-11 · check-in free text available
2021-07-20
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-25
Call 1 — Left Voicemail
2021-07-30
Dose 3 — Pfizer-BioNTech
2021-12-22
Dose 4 — Moderna
2022-01-19
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-12-22
Survey response — 12 months, dose 4
MedDRA: Dyspnoea, Muscular weakness, Pulmonary oedema, Rhinovirus infection, Ventilation perfusion mismatch, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Pre-E 9/15/22 w/ pulm edema, then rhinovirus and now on oxygen when supine, exercising or sleeping (shunt from atelectasis, viral induced neuromuscular weakness and viral mediated disordered breathing)

MedDRA releases: 2024-11 · check-in free text available
2022-12-22
Report sent to call center — 12 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-12-23
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-12-23
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-12-23
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Moderna
2	2021-01-19	Moderna
3	2021-07-30	Pfizer-BioNTech	No
4	2021-12-22	Moderna	No

Call center

3 call center cases

3 successful

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-20

Systemic reaction (other): Severe migraine, had to call of work (never do that)

Release 3 — day 21, dose 2

2021-02-09

Symptoms: Migraine, aches

Release 7 — 3 months, dose 2

2021-04-20

Symptoms: Severe migraine

Release 9 — 6 months, dose 2

2021-07-20

Symptoms: Worsening migraines

Healthcare visit (other): Botox injections

Release 12 — 12 months, dose 4

2022-12-22

Symptoms: Pre-E 9/15/22 w/ pulm edema, then rhinovirus and now on oxygen when supine, exercising or sleeping (shunt from atelectasis, viral induced neuromuscular weakness and viral mediated disordered breathing)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Migraine	✓	✓	✓
SD	Muscular weakness	·	·	✓
SD	Pain	✓	✓	✓
SD	Pulmonary oedema	·	·	✓
SD	Rhinovirus infection	·	·	✓
SD	Ventilation perfusion mismatch	·	·	✓
SD	Viral infection	·	·	✓
SRO	Impaired work ability	✓	✓	✓
SRO	Migraine	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release